Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider Transactions

Date Sorted Ascending Name Title Type Shares Traded Price Range
Jul 20, 2007 cybulski mitchell p. Director Acquisition (Non Open Market) 5,000 n/a
Jul 20, 2007 cybulski mitchell p. Director Statement of Ownership 0 n/a
Jul 20, 2007 fulmer richard Director Acquisition (Non Open Market) 5,000 n/a
Jul 20, 2007 krassner stuart mitchell Director Acquisition (Non Open Market) 5,000 n/a
Jul 20, 2007 kumaria shyam k Officer Acquisition (Non Open Market) 20,000 n/a
Jul 20, 2007 lenaz luigi md Officer Acquisition (Non Open Market) 50,000 n/a
Jul 20, 2007 maida anthony e iii Director Acquisition (Non Open Market) 5,000 n/a
Jul 20, 2007 shrotriya rajesh c md Officer Acquisition (Non Open Market) 100,000 n/a
Jul 20, 2007 Vida, Julius , PH.d. Director Acquisition (Non Open Market) 5,000 n/a
Aug 1, 2007 lenaz luigi md Officer Acquisition (Non Open Market) 5,000 3.58
Aug 1, 2007 shrotriya rajesh c md Officer Acquisition (Non Open Market) 5,000 3.58 - 3.60
Nov 21, 2007 lenaz luigi md Officer Acquisition (Non Open Market) 5,000 2.72
Nov 21, 2007 shrotriya rajesh c md Officer Acquisition (Non Open Market) 10,000 2.70 - 2.79
Nov 26, 2007 kumaria shyam k Officer Acquisition (Non Open Market) 4,000 2.75
Mar 25, 2008 kumaria shyam k Officer Acquisition (Non Open Market) 9,000 n/a
Mar 25, 2008 lenaz luigi md Officer Acquisition (Non Open Market) 18,000 n/a
Mar 25, 2008 shrotriya rajesh c md Officer Acquisition (Non Open Market) 40,000 n/a
May 23, 2008 Vida, Julius , PH.d. Director Acquisition (Non Open Market) 1,200 1.78
Jun 23, 2008 shrotriya rajesh c md Officer Acquisition (Non Open Market) 20,000 1.45 - 1.50
Jun 24, 2008 shrotriya rajesh c md Officer Acquisition (Non Open Market) 10,000 1.43
Showing 1-20 of 234 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
6.60
Change:
+ 0.06
Day High:
6.68
Day Low:
6.54
Volume:
368,332
3:47 PM ET on Mar 24, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR